{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:05:34Z","timestamp":1760385934238,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R268-2016-3925"],"award-info":[{"award-number":["R268-2016-3925"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry Global Open Science"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bpsgos.2022.10.007","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T20:25:47Z","timestamp":1667075147000},"page":"1116-1121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects"],"prefix":"10.1016","volume":"3","author":[{"given":"Nina Vindegaard","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Christine","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Orlovska-Waast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Jeppesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rune Haubo Bojesen","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-9465","authenticated-orcid":false,"given":"Michael Eriksen","family":"Benros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpsgos.2022.10.007_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: Clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1017\/neu.2019.46","article-title":"Characterisation and outcome of neuropsychiatric symptoms in patients with anti-NMDAR encephalitis","volume":"32","author":"Restrepo-Martinez","year":"2020","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti\u2013N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.679996","article-title":"Case report: Severe adolescent major depressive syndrome turns out to be an unusual case of anti-NMDA receptor encephalitis","volume":"12","author":"Moldavski","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib5","first-page":"1618","article-title":"NMDA-receptor encephalitis in Denmark from 2009 to 2019: A national cohort study","volume":"269","author":"Nissen","year":"2022","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss","year":"2021","journal-title":"Nat Rev Immunol"},{"year":"2018","series-title":"Neurology Mosaics instructions for the indirect immunofluorescence test","key":"10.1016\/j.bpsgos.2022.10.007_bib9"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it\u2019s the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib11","article-title":"Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach","volume":"9","author":"Hansen","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jad.2016.03.030","article-title":"Evidence of cerebrospinal fluid abnormalities in patients with depressive syndromes","volume":"198","author":"Endres","year":"2016","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176358","article-title":"Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters","volume":"12","author":"Fernstr\u00f6m","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib14","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1017\/S0033291716002038","article-title":"Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care","volume":"46","author":"Schou","year":"2016","journal-title":"Psychol Med"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","article-title":"Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: Healthy control samples revisited","volume":"71","author":"Steiner","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib17","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1212\/NXI.0000000000000386","article-title":"Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity","volume":"4","author":"Lang","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: An international consensus on an approach to the diagnosis and management of\u00a0psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12888-021-03633-0","article-title":"Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression\u2014a study protocol","volume":"22","author":"S\u00f8rensen","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.biopsych.2022.04.002","article-title":"Neuroinflammatory biomarkers in cerebrospinal fluid from 106 patients with recent-onset depression compared with 106 individually matched healthy control subjects","volume":"92","author":"S\u00f8rensen","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archpsyc.1990.01810180089012","article-title":"SCAN. Schedules for Clinical Assessment in Neuropsychiatry","volume":"47","author":"Wing","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental State Examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","article-title":"The Brief Assessment of Cognition in Schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery","volume":"68","author":"Keefe","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1192\/bjp.bp.107.045450","article-title":"Neurological abnormalities and cognitive ability in first-episode psychosis","volume":"193","author":"Dazzan","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A\u00a0clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/jamapsychiatry.2015.0526","article-title":"Absence of N-methyl-D-aspartate receptor IgG autoantibodies in schizophrenia: The importance of cross-validation studies","volume":"72","author":"de Witte","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.654602","article-title":"Neural autoantibodies in cerebrospinal fluid and serum in clinical high risk for psychosis, first-episode psychosis, and healthy volunteers","volume":"12","author":"Bien","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41398-021-01701-3","article-title":"Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis","volume":"11","author":"Theorell","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: Proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib31","doi-asserted-by":"crossref","first-page":"e1127","DOI":"10.1212\/NXI.0000000000001127","article-title":"Anti-NMDAR encephalitis in the Netherlands, focusing on late-onset patients and antibody test accuracy","volume":"9","author":"Bastiaansen","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","article-title":"Autoimmune encephalitis: Clinical spectrum and management","volume":"21","author":"Uy","year":"2021","journal-title":"Pract Neurol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fimmu.2017.00181","article-title":"Autoantibodies against the N-methyl-D-aspartate receptor subunit NR1: Untangling apparent inconsistencies for clinical practice","volume":"8","author":"Ehrenreich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/brainsci11060673","article-title":"Mild amnestic cognitive impairment and depressive symptoms in autoimmune encephalitis associated with serum anti-neurexin-3\u03b1 autoantibodies","volume":"11","author":"Hansen","year":"2021","journal-title":"Brain Sci"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2017.06.015","article-title":"Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE Project","volume":"82","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.biopsych.2022.02.010","article-title":"Spectrum of novel anti-central nervous system autoantibodies in the cerebrospinal fluid of 119 patients with schizophreniform and affective disorders","volume":"92","author":"Endres","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib37","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib38","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bpsgos.2022.10.007_bib39","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-017-01700-3","article-title":"Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients","volume":"8","author":"J\u00e9z\u00e9quel","year":"2017","journal-title":"Nat Commun"}],"container-title":["Biological Psychiatry Global Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174322001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667174322001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:53:13Z","timestamp":1757404393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667174322001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2667174322001392"],"URL":"https:\/\/doi.org\/10.1016\/j.bpsgos.2022.10.007","relation":{},"ISSN":["2667-1743"],"issn-type":[{"type":"print","value":"2667-1743"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry Global Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpsgos.2022.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc on behalf of Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}